Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-08-26 10:01 am Purchase | 13G | Eiger BioPharmaceuticals Inc. EIGR | Arkin Moshe | 149,371 10.090% | 96,300 (+181.46%) | View |
| 2024-07-01 06:47 am Sale | 13D | Eiger BioPharmaceuticals Inc. EIGR | Arkin Moshe | 53,071 3.580% | -4,428,055 (-98.82%) | View |
| 2024-05-10 2:14 pm Sale | 13G | Eiger BioPharmaceuticals Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 0 0.000% | -7,505,539 (Position Closed) | View |
| 2024-02-14 4:03 pm Sale | 13G | Eiger BioPharmaceuticals Inc. EIGR | 683 Capital Management LLC | 70,000 4.700% | -3,045,000 (-97.75%) | View |
| 2024-02-14 10:55 am Sale | 13G | Eiger BioPharmaceuticals Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 7,505,539 16.910% | -523,383 (-6.52%) | View |
| 2023-12-04 06:01 am Sale | 13D | Eiger BioPharmaceuticals Inc. EIGR | Arkin Moshe | 4,481,126 10.090% | -1,000 (-0.02%) | View |
| 2023-11-24 06:01 am Unchanged | 13D | Eiger BioPharmaceuticals Inc. EIGR | Arkin Moshe | 4,482,126 10.090% | 0 (Unchanged) | View |
| 2023-11-02 9:54 pm Purchase | 13D | Eiger BioPharmaceuticals Inc. EIGR | Propel Bio Management LLC | 5,375,225 12.130% | 278,239 (+5.46%) | View |
| 2023-10-20 4:29 pm Purchase | 13D | Eiger BioPharmaceuticals Inc. EIGR | Propel Bio Management LLC | 5,096,986 11.510% | 273,048 (+5.66%) | View |
| 2023-09-28 4:54 pm Purchase | 13G | Eiger BioPharmaceuticals Inc. EIGR | Propel Bio Management LLC | 4,823,938 10.900% | 2,431,771 (+101.66%) | View |
| 2023-08-15 06:00 am Purchase | 13G | Eiger BioPharmaceuticals Inc. EIGR | Propel Bio Management LLC | 2,392,167 5.400% | 2,392,167 (New Position) | View |
| 2023-07-07 4:35 pm Sale | 13G | Eiger BioPharmaceuticals Inc. EIGR | BlackRock Inc. BLK | 937,125 2.100% | -1,918,565 (-67.18%) | View |
| 2023-04-18 09:59 am Purchase | 13G | Eiger BioPharmaceuticals Inc. EIGR | Arkin Moshe | 4,482,126 10.150% | 1,769,124 (+65.21%) | View |
| 2023-04-10 1:37 pm Purchase | 13G | Eiger BioPharmaceuticals Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 8,028,922 18.220% | 2,584,166 (+47.46%) | View |
| 2023-02-14 2:23 pm Sale | 13G | Eiger BioPharmaceuticals Inc. EIGR | 683 Capital Management LLC | 3,115,000 7.100% | -185,000 (-5.61%) | View |
| 2023-02-09 10:57 am Sale | 13G | Eiger BioPharmaceuticals Inc. EIGR | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -2,800,000 (Position Closed) | View |
| 2023-02-06 3:34 pm Purchase | 13G | Eiger BioPharmaceuticals Inc. EIGR | BlackRock Inc. BLK | 2,855,690 6.500% | 382,726 (+15.48%) | View |
| 2023-02-02 2:25 pm Purchase | 13G | Eiger BioPharmaceuticals Inc. EIGR | Arkin Moshe | 2,713,002 6.160% | 886,776 (+48.56%) | View |
| 2023-01-10 12:12 pm Sale | 13G | Eiger BioPharmaceuticals Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 5,444,756 12.350% | -2,145,370 (-28.27%) | View |
| 2022-05-11 3:01 pm Purchase | 13G | Eiger BioPharmaceuticals Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 7,590,126 17.560% | 541,292 (+7.68%) | View |